HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein

Biochemical and Biophysical Research Communications

Volumn 311, Issue 4, 2003, Pages 1057-1066

  Xu, Zhenhua ^a   Liang, Liang ^a   Wang, Hongfei ^a   Li, Tsaiping ^a   Zhao, Mujun ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

cDNA; Colony formation; Growth inhibitor; Hepatoma; RNA interference

Indexed keywords

COMPLEMENTARY DNA; GROWTH INHIBITOR; HEPATOCELLULAR CARCINOMA RELATED PROTEIN 1; PROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ANCHORAGE; CELL GROWTH; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE ISOLATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC CODE; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; LIVER; LIVER CELL CARCINOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA ANALYSIS; TRANSGENE;

EID: 0242690219     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.10.109     Document Type: Article

References (36)

1. Bishop J.M. The molecular genetics of cancer. Science. 235:1987;305-311.
2. Feitelson M.A., Sun B., Satiroglu Tufan N.L., Liu J., Pan J., Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene. 21:2002;2593-2604.
3. Nagai H., Pineau P., Tiollais P., Buendia M.A., Dejean A. Comprehensive alleotyping of human hepatocellular carcinoma. Oncogene. 14:1997;2927-2933.
4. Emi M., Fujiwara Y., Nakajima T., Tsuchiya E., Tsuda H., Hirohashi S., Maeda Y., Tsuruta K., Miyaki M., Nakamura Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer and lung cancer. Cancer Res. 52:1992;5368-5372.
5. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Oamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H. Alleotype study of primary hepatocellular carcinoma. Cancer Res. 51:1991;89-93.
6. Pineau P., Nagai H., Prigent S., Wei Y., Gyapay G., Weissenbach J., Tiollais P., Buendia M.A., Dejean A. Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinom. Oncogene. 18:1999;3127-3134.
7. Zhou X., Lu K. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell. 107:2001;347-359.
8. Liao C., Zhao M., Song H., Uchida K., Yokoyama K., Li Z. Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology. 32:2000;721-727.
9. Yuan B.Z., Miller M.J., Keck C.L., Zimonjic D.B., Thorgeirsson S.S., Popescu N.C. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res. 58:1998;2196-2199.
10. Ng I.O., Liang Z.D., Cao L., Lee T.K. DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res. 60:2000;6581-6584.
11. Yuan B.Z., Zhou X., Durkin M.E., Zimonjic D.B., Gumundsdottir K., Eyfjord J.E., Thorgeirsson S.S., Popescu N.C. DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity. Oncogene. 22:2003;445-450.
12. Xu Y., Uberbacher E.C. Automated gene identification in large-scale genomic sequences. J. Comput. Biol. 4:1997;325-328.
13. Altschul S.F., Stephen F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
14. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning, A Laboratory Manual. second ed. 1989;Cold Spring Harbor Laboratory Press, New York.
15. Supino R. MTT assays. O'Hare S., Atterwill C.K. Methods in Molecular Biology. Volume 43: In Vitro Toxicity Testing Protocols. 1995;744-746 Humana Press Inc, Totoa, NJ.
16. Lee N.S., Dohjima T., Bauer G., Li H., Li M., Ehsani A., Salvaterra P., Rossi J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotech. 19:2002;500-505.
17. Cher M.L., Macgrogan D., Bookstein R., Brown J.A., Jenkins R.B., Jensen R.H. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosome Cancer. 11:1994;153-162.
18. Macoska J.A., Trybus T.M., Benson P.D., Sakr W.A., Grignon D.J., Wojno K.D., Pietruk T., Powell I.J. Evidence for three tumor suppressor genes loci on chromosome 8p in human prostate cancer. Cancer Res. 55:1995;5390-5395.
19. Chuagui R.F., Sanz-Ortega J., Vocke C., Linehan W.M., Sanz-Esponera J., Zhuang Z., Emmert-Buck M.R., Merino M.J. Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas. Cancer Res. 55:1995;4995-4998.
20. Wistuba I.I., Behren C., Virmani A.K., Milchgrub S., Syed S., Lam S., Mackay B., Minna J.D., Gazdar A.F. Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res. 59:1999;1973-1979.
21. Fujiwara Y., Emi M., Ohata H., Kato Y., Nakajima T., Mori T., Nakamura Y. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res. 53:1993;1172-1174.
22. Ohgaki K., Iida A., Ogawa O., Kubota Y., Akimoto M., Emi M. Localization of tumor suppressor gene associated with distant metastasis of urinary bladder cancer to a 1-Mb interval on 8p22. Genes Chromosome Cancer. 25:1999;1-5.
23. Naggar A.K., Hurr K., Batsakis J.G., Luna M.A., Goepfert H., Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res. 55:1995;2656-2659.
24. Brenner S.E., Chothia C., Hubbard T.J. Assessing sequence comparison methods with reliable structurally identified distant evolutionary relationships. Proc. Natl. Acad. Sci. USA. 95:1998;6073-6078.
25. Huynen M., Doerks T., Eisenhaber F., Orengo C., Sunyaev S., Yuan Y., Bork P. Homology-based fold predictions for mycoplasma genitalium proteins. J. Mol. Biol. 280:1998;323-326.
26. Mushegian A.R., Bassett D.E., Boguski M.S., Bork P., Koonin E.V. Positionally cloned human disease genes: patterns of evolutionary conservation and functional motifs. Proc. Natl. Acad. Sci. USA. 94:1997;5831-5836.
27. Koonin E.V., Abagyan R.A. TSG101 may be the prototype of a class of dominant negative ubiquitin regulators. Nat. Genet. 16:1997;330-331.
28. Li L.M., Cohen S.N. tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell. 85:1996;319-329.
29. Hannon G.J. RNA interference. Nature. 418:2002;244-251.
30. Paul C.P., Good P.D., Winer I., Engelke D.R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20:2002;505-508.
31. Qin L., Tang Z., Sham J., Ma Z., Ye S., Zhou X., Wu Z., Trent J.M., Guan X. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res. 59:1999;5662-5665.
32. Yokota T., Toshimoto M., Akiyama F., Sakamoto G., Kasumi F., Nakamura Y., Emi M. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1. Cancer. 85:1999;447-452.
33. Wanger U., Bubendorf L., Gasser T.C., Moch H., Gorog J.P., Richter J., Mihatsch M.J., Waldman F.M., Sauter G. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. Am. J. Pathol. 151:1997;753-759.
34. Li L., Price J.E., Fan D., Zhang R., Bucana C., Fiddler I.J. Correlation of growth capacity of human tumor cells in hard agarose with their in vitro proliferative capacity at specific metastatic sites. J. Natl. Cancer Inst. 81:1989;1406-1412.
35. Haber D., Harlow E. Tumor-suppressor genes: evolving definitions in the genomic age. Nat. Genet. 16:1997;320-322.
36. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA. 68:1971;820-823.